Replies to post #13 on Dicerna Pharmaceuticals, Inc. (DRNA)

[XenaLives]

This?

Net Loss – Net loss was $40.8 million, or $0.53 per share, for the second quarter ended June 30, 2021, compared to a net loss of $31.8 million, or $0.43 per share, for the same period in 2020.

https://investors.dicerna.com/node/13526/html

[ok2buy]

US politics is driving the market lower in general. The DEMS and the REPUBS need to agree on money required to pay the existing debt and define the debt ceiling (if there is to be one). The market hates uncertainty. IMO, nothing wrong with the company. When the NAZ is moving lower by 300 - 400 points on numerous days you know there is trouble./ok2